India to United States: Temozolomide Export Trade Route
India has recorded 82 verified shipments of Temozolomide exported to United States, representing a combined trade value of $648.0K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $7.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 54% of total export value with 42 shipments worth $350.2K USD. On the buying side, RISING PHARMA HOLDINGS, INC. ,. is the largest importer in United States with $120.4K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Temozolomide corridor is one of India's established pharmaceutical export routes, with 82 shipments documented worth a combined $648.0K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $7.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 18.2%, placing it at rank #15 among India's top temozolomide export destinations globally.
On the import side, key buyers of Indian temozolomide in United States include RISING PHARMA HOLDINGS, INC. ,., SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC. and 12 others. RISING PHARMA HOLDINGS, INC. ,. is the single largest importer with 9 shipments valued at $120.4K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#15
- Annual growth+18.2%
- Demand growth+15.7%
- Regulatory ease87/100
Top 10 Indian Temozolomide Exporters to United States
Showing top 10 of 9 Indian suppliers exporting Temozolomide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $8.3K per shipment | 42 | $350.2K | 54.0% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $11.4K per shipment | 15 | $171.1K | 26.4% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $6.2K per shipment | 16 | $98.5K | 15.2% |
| 4 | INTAS PHARMACEUTICALS LTD Avg $14.3K per shipment | 1 | $14.3K | 2.2% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $3.2K per shipment | 4 | $13.0K | 2.0% |
| 6 | VINAYAK ASSOCIATES Avg $404 per shipment | 1 | $404 | 0.1% |
| 7 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $324 per shipment | 1 | $324 | 0.0% |
| 8 | VEA IMPEX (I) PRIVATE LIMITED Avg $111 per shipment | 1 | $111 | 0.0% |
| 9 | MERIT POLYCHEM PVT. LTD. Avg $23 per shipment | 1 | $23 | 0.0% |
This table shows the top 10 of 9 Indian companies exporting temozolomide to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, SUN PHARMACEUTICAL INDUSTRIES LTD, VINAYAK ASSOCIATES, MYGENIC HEALTHCARE PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, MERIT POLYCHEM PVT. LTD.. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 42 shipments worth $350.2K USD, giving it a 54% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Top 10 Temozolomide Importers in United States
Showing top 10 of 15 known buyers in United States receiving Temozolomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian temozolomide in United States include RISING PHARMA HOLDINGS, INC. ,., SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., EVERSANA LIFE SCIENCES SERVICES,LLC, SUN PHARMACEUTICAL INDUSTRIES,INC, among 15 total buyers. The largest importer is RISING PHARMA HOLDINGS, INC. ,., accounting for $120.4K USD across 9 shipments — representing 19% of all temozolomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RISING PHARMA HOLDINGS, INC. ,. | 9 | $120.4K | 18.6% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES INC | 18 | $108.7K | 16.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 13 | $105.6K | 16.3% |
| 4 | EVERSANA LIFE SCIENCES SERVICES,LLC | 16 | $98.5K | 15.2% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES,INC | 9 | $75.5K | 11.7% |
| 6 | SUN PHARMACEUTICAL INDUSTRIESINC. | 3 | $54.2K | 8.4% |
| 7 | RISING PHARMA HOLDINGS INC | 6 | $50.7K | 7.8% |
| 8 | EVERSANA LIFE SCIENCES SERVICES LLC | 1 | $14.3K | 2.2% |
| 9 | M S | 1 | $8.3K | 1.3% |
| 10 | M/S | 1 | $7.0K | 1.1% |
Showing top 10 of 15 Temozolomide importers in United States on this route.
Top 10 Temozolomide Formulations Imported by United States
Showing top 10 of 68 product formulations shipped on the India to United States Temozolomide route, ranked by trade value
United States imports a wide range of temozolomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHA.DRU & MEDI, TEMOZOL USP -100MG-5C-AMBER(US-ACCO EACH HARD GELATIN CAPSULE CONTAINS TEMOZOLOMIDE 100 MG 11912X1X5CNOS — accounts for $49.0K USD across 3 shipments. There are 68 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHA.DRU & MEDI, TEMOZOL USP -100MG-5C-AMBER(US-ACCO EACH HARD GELATIN CAPSULE CONTAINS TEMOZOLOMIDE 100 MG 11912X1X5CNOS | 3 | $49.0K | 7.6% |
| 2 | TEMOZOLOMIDE CAPSULES 180 MG (TEMOZOLOMIDE CAPSULES USP 180 MG) (1545X14'S) | 1 | $31.5K | 4.9% |
| 3 | TEMOZOLOMIDE CAPSULES USP 100 MG PACK 5s Strip BATCH NO AS PER INVOICE | 1 | $27.0K | 4.2% |
| 4 | TEMOZOLOMIDE 100 MG CAPSULE PACK : 5S STRIP (BATCH DETAILS AS PER INVOICE)NOS | 1 | $26.5K | 4.1% |
| 5 | TEMOZOLOMIDE CAPSULES 180 MG PACK : 5SSTRIP (BATCH DETAILS AS PER INVOICE)NOS | 1 | $25.8K | 4.0% |
| 6 | TEMOZOLOMIDE CAPSULES USP 100MG 4320 PACK X 5 STRIP | 1 | $25.6K | 4.0% |
| 7 | PHA.DRU & MEDI, TEMOZOL USP -100MG-14C-AMBER(US-ACCO EACH HARD GELATIN CAPSULE CONTAINS TEMOZOLOMIDE 100 MG 2372X1X14CNOS | 3 | $25.6K | 4.0% |
| 8 | TEMOZOLOMIDE CAPSULES USP,100 MG (PACK :5s Strip) | 1 | $24.3K | 3.7% |
| 9 | TEMOZOLOMIDE CAPSULE USP 140 MG, PACK :5s Strip, Batch : HAF2700A MFD : 10.12.2024 EXP : 30.11.2026 | 1 | $22.7K | 3.5% |
| 10 | TEMOZOLOMIDE CAPSULES 100 MG (TEMOZOLOMIDE CAPSULES USP 100 MG) (1869X14'S) | 1 | $21.9K | 3.4% |
Showing top 10 of 68 Temozolomide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 27 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's temozolomide exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 42 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 96% of total trade value on this route. The average shipment value of $7.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as temozolomide capsules 180 mg (temozolomide capsules usp 180 mg) (1545x14's) and temozolomide capsules usp 100 mg pack 5s strip batch no as per invoice, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, RISING PHARMA HOLDINGS, INC. ,. is the largest importer with 9 shipments worth $120.4K USD — representing 19% of all temozolomide imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $648.0K
- Avg. Shipment
- $7.9K
- Suppliers
- 9
- Buyers
- 15
- Transit (Sea)
- ~24 days
- Annual Growth
- +18.2%
Related Analysis
Other Temozolomide Routes
Unlock the Full India to United States Temozolomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 82 shipments on this route.
Frequently Asked Questions — India to United States Temozolomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Temozolomide to United States?
The leading Indian exporters of Temozolomide to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Temozolomide exports from India to United States?
India exports Temozolomide to United States worth approximately $648.0K USD across 82 recorded shipments. The average value per shipment is $7.9K USD.
Q Which ports does India use to ship Temozolomide to United States?
The most active port of origin is SAHAR AIR with 27 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Temozolomide?
The average transit time for Temozolomide shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Temozolomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.2% with demand growth tracking at 15.7%. The route is ranked #15 among India's top Temozolomide export destinations globally.
Q How many suppliers are active on the India to United States Temozolomide route?
There are currently 9 active Indian suppliers exporting Temozolomide to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 54% of total shipment value.
Q Who are the main importers of Temozolomide from India in United States?
The leading importers of Indian Temozolomide in United States include RISING PHARMA HOLDINGS, INC. ,., SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., EVERSANA LIFE SCIENCES SERVICES,LLC, SUN PHARMACEUTICAL INDUSTRIES,INC. RISING PHARMA HOLDINGS, INC. ,. is the largest buyer with 9 shipments worth $120.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Temozolomide.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 15 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 82 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
82 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists